In a sweeping move intended to prevent further cases of infant botulism, ByHeart, a producer of organic baby formula, has recalled all of its products nationally. This decision comes after the company's preliminary recall of two separate lots this past Saturday. The recall affects both ByHeart Whole Nutrition Infant Formula and Anywhere Pack pouches of powdered formula. This comes in the wake of at least 15 infants across 12 states being hospitalized due to the outbreak since August, as per reports from state and federal health officials. Despite numerous sickened infants, there have thankfully been no reports of fatalities. Parents and caregivers have been advised to "immediately discontinue use and dispose of the product," according to 25 News Now, citing Dr. Devon Kuehn, the company's chief medical officer.
The recall expansion was triggered following discussions with the U.S. Food and Drug Administration (FDA), which discovered additional cases linked to the formula. ByHeart's cofounders, Mia Funt and Ron Belldegrun, indicated through an open letter on their website that the FDA has reported two more cases of infant botulism in babies that had consumed ByHeart products. Despite no unopened ByHeart products testing positive for Clostridium botulinum spores or toxins, the company is taking significant precautions. The cofounders conveyed their commitment to safety, saying, "Your baby's safety is, and always will be, our biggest priority," according to CBS News.
ByHeart holds roughly 1% of the infant formula market share in the United States, yet their products represented a disproportionate number of the 36 formula-related botulism cases reported by the FDA. The severity of this situation has not only led to the comprehensive recall but has also resulted in the brand eagerly complying with regulatory bodies. They've begun to test every batch of formula through an independent laboratory and opened their facilities for inspection without restriction. Health officials in California have previously confirmed that an open can of ByHeart fed to an affected infant did contain the bacteria responsible for the toxin associated with the outbreak.
The FDA, in its scrutiny of infant botulism, has reported investigating 84 cases since August. The agency noted in a statement that more than a third of the infants who consumed formula and became ill had been fed ByHeart. The company's formula powder is produced at a plant in Allerton, Iowa, before being canned and distributed from Portland, Oregon—a facility that was recently subject to an FDA inspection, Kuehn disclosed to 25 News Now. The rare illness affects babies under one year old, and it's particularly serious given their immature gut microbiomes. Symptoms to watch for include constipation, poor feeding, and difficulty swallowing, among others. Immediate medical attention can be critical, with the sole treatment being BabyBIG, an IV medication made from the blood plasma of people immunized against botulism.
